Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Actually their history is filing bogus shit for the most part and more than that threatening lawsuits with no merit. Their investigation will never turn into any thing here
This is usually their last tactic. Seen it a million times, from this exact firm.
There is no lawsuit. This is an “investigation”. These clowns do this all the time
Immediately when anything happens this douchebags come out of the woods. Tried this with alibaba a while back, failed miserably
These are always a joke. Ambulance chasers.
If the stock price can hold $20 and climb today that would be a massive loss for the hit squad and their articles. The company has done a good job of refuting the misinformation.
Given all that happened today, closing at just under $20 is a pretty good close. Easy for the price to jump back into the 20’s. I feel like bears did their worst today and emptied their ammo.
The big investors weren’t scared out today, the amateur trading wannabe guys were is my guess. I think you will see institutional buying tick up as the week progresses but wouldn’t doubt it started in good numbers today on the dive.
Give it time. The negative articles will subside and the script numbers will rise. Since the negative articles are basically trying to say you can’t trust the trial, the fact the price is at $19 isn’t looking good for them long term. If the study had serious flaws, the price would be under $10 in a blink. Dilution is the next scare tactic they will use, but eventually that doesn’t work either.
Probably. Went down further than I thought, but long run that’s a gift IMO. Big volume coming today
I did the same. When the price got below $18, I quickly sold some other holdings. Can’t see the price not rebounding from here
Agreed. This is a great buying opportunity. The very short term stuff will shake out. Just added here, happy to get more
Because there are plenty of people who played this simply for a quick hit today. Easy to get those people to sell, most likely didn’t even read the results. Just trading it
The new buyers aren’t going to all flood the market tomorrow, doesn’t work that way. Listen I hope I am wrong and nothing would make me happier, but I’ve seen many things happen in 25 years of trading/investing that you would never expect and being a market maker for a good part of my career, know a lot of the games played. Perhaps buying will be over the top huge, which mitigates the games.
I think you will be surprised and it opens right about $22 a share. For the first day market makers are going to think (likely correctly) that a bunch of weak handed people will sell out if the price doesn’t move immediately. Not really people on this board, but a lot of people bought in the last few days just for a quick hit. I could see the price being held down to panic those people into selling so they can pick up cheap shares. I hope I’m wrong but I’ll buy more than ready to add if I am not. Over the next month I think we will touch $35-$40 with the bigger jumps coming next year.
I think analysts like the one at Citibank suddenly rethinking his $28 PT
Diabetic and pre-diabetic uses for Vascepa? Damn that’s is beyond what I would have hoped for
If this stock price got anywhere near $12 it certainly wouldn’t stop there. The price isn’t going anywhere near $12.
I would expect the company to do a good job tonight at the investor conference. They had to expect the hit pieces and questions and I’m sure will be ready handle them.
You may or may not. Bottom line though is the hit pieces aren’t likely to have long term or even medium term effect on the SP. scripts will rise tremendously and SP will do the same. I’m certainly ready for Monday with more cash if the market allows me to get shares anywhere near $22.
Will be important to debunk articles like this in major investing publications
If this happens a lot of folks I know would either buy more or buy in new. Assuming the data is great, honestly it’s not a big concern where the stock price is short term, the data will win out and so would anyone buying shares on the drop. Doubt it happens but I for one would be fine doubling my investment with knowledge the data and results are breakthrough.
The 70,500 bid at $21.90 here at the close wasn’t a MM game, that’s a real bid. No way there is interest to push below that into the close. Someone wants a lot more shares
Excited to pick up another good chunk in the $21.60 area. Never thought we would return down there, weak hand people are so easily shook, which is great.
Completely agreed. No company hiding spotty data would put out even the first release with the earnings calling their drug potentially groundbreaking. The fact they haven’t backed off that bravado is the reason I continue to add shares on any dips.
He can’t pick stocks to save his life anymore. His portfolio of stocks he sells is a joke and has woefully underperformed the S&P for 10 years running. He is good for the sheep who don’t understand the market.
As of 2017, looks like the 1% starts at roughly $719k.
A pure trash site. Estimates are always ridiculous
I’m an accountant myself but not
Specifically at tax accountant. That said we have a similar situation I was just speaking to our tax accountants on this past week to confirm. In the US, you must make estimated payments of at least 90% of your current year estimated tax OR 100% of the tax of your last year’s tax return to avoid underpayment penalty. Always best to check with your tax accountant to make sure your particular situation doesn’t vary, but selling at the beginning of the next year for large transactions is a common way to delay your tax bill and not be required to pay estimated payments on the large amount as long as you pay 100% of the prior year tax in your estimates.
It takes talent to play both sides of the fence. It’s overvalued and only destined to go lower from here, unless an irrational market takes it higher. Mmm, ok, check.
I one of the only people here it seems who doesn’t a million shares at $3 (more like 5k I the high 17’s), but my wife works for a very large health care company and I’ve surveyed enough cardiologists and others to have a solid opinion that at $22 and no secondary, AMRN isn’t close to its peak moving forward.
The mitigating factor for people sitting the sidelines to wait for execution is the potential for a buyout and the fact they would miss the jump. If everything goes as planned on the 10th, it confirms Amarin as major buyout target that could be closed at any time.
Options are certainly aren’t anywhere near as liquid as the stock will be and many more games are played with options. That said, for an active stock like AMRN, there is always prices to deal on in the options market especially for in the money options strike prices. I would expect options in AMRN to see increased volumes going into the 10th
You simply sell the option and exit the position. No need to exercise the option unless the market is pricing an in the money contract at an unfair price.
Market makers simply look for and run stop losses, it’s the easiest way for them to gain volatility and make more money. Honestly there is no reason for high volume now as everyone still waiting on the news. With that said low volume equal easy manipulations till you find the true buyers/sellers. No different in this stock than all the others in that respect.
Yep that sounds right. Today’s price allowed Amarin to exercise their option to force conversion of the notes from debt to stock, as it was the 20th trading day above the weighted price of $5.05
6 years isn’t enough patience. 10
Years perhaps? In the meanwhile you miss the best bull market in history lmao
Well the stock has dead money for about 6 year now. Acquiring new bag holders daily
Most people pull their bids and offers before the CC, especially on a very small OTC stock. It’s all about what is said now.
They aren’t dips if the price keeps coming back to the same place. Pretty straight forward
Actually what you have traditionally seen in ELTP is a hard dive after the earnings and conference call. The scenario you are referring to, has not been very prevalent in this stock.